ePrivacy and GPDR Cookie Consent by TermsFeed Generator

AESCIN TEVA

20MG TBL ENT 90

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 13.07.2021
Interruption of marketing 31.05.2021 0107806, 0208838, 0234216
Manufacturing reasons 20.06.2021
Resumption of marketing 25.11.2020
Interruption of marketing 30.11.2019 0107806, 0208838, 0208839
Manufacturing reasons 12/2019
Resumption of marketing 01.04.2016
Interruption of marketing 01.03.2016 0107806
Resumption of marketing 01.01.2016
Interruption of marketing 27.07.2015 0107806
Resumption of marketing 15.02.2015
Interruption of marketing 15.02.2015 0107806
Placing on the market 23.05.2014

All reports are available in the Overview.

Back to list